 iib osteosarcoma current manag surviv statist ussr ninety-thre patient iib osteosarcoma author institut first stage studi patient surgeri five-year disease-fre surviv rate second stage studi efficaci prevent chemotherapi radic surgeri patient five-year disease-fre surviv rate third stage studi efficaci combin therapi preoper treatment limb-sav surgeri prevent chemotherapi patient five-year disease-fre surviv rate author result patient grade IV relationship prognosi morphogen chang preoper radiotherapi chemotherapi five-year disease-fre surviv rate fourth stage studi regimen preoper chemotherapi first regimen intraarteri platinum infus patient extrem bone damag second regimen high-dos methotrex infus preliminari conclus primari tumor damag mark intraarteri cisplatin infus